Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance

Ítems similars

• Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
  per: Nicole Bertoletti, et al.
  Publicat: (2020-10-01)
• Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
  per: Bertoletti, Nicole, et al.
  Publicat: (2019)
• Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides
  per: Vastmans, Karen, et al.
  Publicat: (2001)
• Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol
  per: Mislak, Andrea C., et al.
  Publicat: (2015)
• Mechanistic and Kinetic Differences between Reverse Transcriptases of Vpx Coding and Non-coding Lentiviruses
  per: Lenzi, Gina M., et al.
  Publicat: (2015)